Glenmark Life Sciences Rebrands to Alivus Life Sciences After Nirma Acquisition

MT Newswires Live
01-20

Glenmark Life Sciences (NSE:GLS, BOM:543322) has rebranded to Alivus Life Sciences following its acquisition by Nirma, the company said in a Saturday release filed with the Indian stock exchanges.

The company said its BSE symbol remains unchanged, while the NSE symbol has changed to ALIVUS from GLS effective Jan. 20.

Glenmark Life Sciences share were up 0.2% in recent trading activity.

Price (INR): ₹1086.00, Change: ₹+1.7, Percent Change: +0.15%

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10